Elevated IL-1β, TNF- α, IL-18, and PTX3 levels in HIV patients with histoplasmosis could serve as a potential predictive biomarker for poor prognosis and disseminated disease development in these individuals. This evidence concerns the gene IL18 and histoplasmosis.